SUPPLY AGREEMENTSupply Agreement • March 20th, 2023 • Athenex, Inc. • Pharmaceutical preparations • Hong Kong
THIS SUPPLY AGREEMENT (this “Agreement”) is entered into as of November 16, 2022, (the “Effective Date”), by and between Athenex, Inc., a Delaware corporation with an address at 1001 Main Street, Suite 600, Buffalo, New York 14203 (“Athenex”), and Chongqing Taihao Pharmaceutical Co., Ltd. (重庆泰濠制药有限公司) with an address at No. 105 Erlang Chuangye Road, Jiulongpo District, Chongqing, China (“Chongqing Taihao”) and Chongqing Sintaho Pharmaceutical Co., Ltd. (重庆兴泰濠制药有限公司) with an address at 600 Liuqing Road, Maliuzui Town, Banan District, Chongqing 401319, China (“Chongqing Sintaho”) (Chongqing Taihao and Chongqing Sintaho together the “Supplier”) and ATNX SPV, LLC, a Delaware limited liability company (“SPV”). Supplier and Athenex together shall be referred to in this Agreement as the “Parties” and individually as a “Party”. The SPV is solely a party to this Agreement to give effect as set forth herein.
